Opioid Use After Traumatic Injury in Adolescents
NCT03628846 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 123
Last updated 2023-05-19
Summary
Currently, 1 in 8 adolescents continue to receive prescription opioids a year or more after injury. By longitudinally surveying patients, we can identify risk factors and pathways to nonmedical opioid use. Furthermore, by assessing whether pain management and mental health treatment after injury moderates sustained opioid use and prescription opioid misuse, we can create targeted interventions to reduce future nonmedical opioid use in adolescents.
Conditions
- Opioid Use
- Traumatic Injury
- Adolescent Behavior
- Substance Abuse Disorder
Sponsors & Collaborators
-
Indiana University
lead OTHER
Eligibility
- Min Age
- 12 Years
- Max Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-07-01
- Primary Completion
- 2023-03-31
- Completion
- 2023-04-30
Countries
- United States
Study Locations
More Related Trials
-
Buprenorphine as a Post-operative Analgesic in Opioid-Naive Patients After Ankle Fracture Surgery
NCT06949826 ·Status: RECRUITING ·Phase: PHASE4
-
The Effects of Opioid Taper on Opioid-Induced Hyperalgesia
NCT03063905 ·Status: TERMINATED
-
Collaborative Care From the ED for Trauma Patients With Prescription Drug Misuse
NCT02804295 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate Unintended Prolonged Opioid Use
NCT04024397 ·Status: COMPLETED
-
A Prospective Investigation of the Risks of Opioid Misuse, Abuse, and Addiction Among Patients Treated With Opioids for the Treatment of Chronic Pain
NCT02751762 ·Status: COMPLETED
-
Study of the Treatment of Experimental Pain in Buprenorphine Maintained Persons With Chronic Musculoskeletal Pain
NCT02372591 ·Status: COMPLETED ·Phase: PHASE1
-
Safe Return and Disposal of Unused Opioids
NCT03352479 ·Status: WITHDRAWN ·Phase: NA
-
Optimal Dose of Prophylactic Naloxone in Reducing Opioid-Induced Side Effects in Children/Adolescents
NCT00330343 ·Status: COMPLETED ·Phase: PHASE2
-
Safe Opioid Prescription Practice for Patients Discharged From Trauma Services
NCT02584881 ·Status: UNKNOWN ·Phase: NA
-
Pharmacokinetics, Safety, and Efficacy of Intravenous Dosing of Buprenorphine in Pediatric Patients Who Require Opioid Analgesia for Acute Moderate to Severe Pain
NCT01324544 ·Status: WITHDRAWN ·Phase: PHASE3
-
Screening in Trauma for Opioid Misuse Prevention
NCT02861976 ·Status: COMPLETED
-
Sensory Outcomes in Active Substance Users
NCT06639438 ·Status: RECRUITING
-
Buprenorphine as a Treatment for Individuals Dependent on Analgesic Opioids
NCT00218101 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Buprenorphine and Naloxone in Opiate Addicts - 4
NCT00000355 ·Status: COMPLETED ·Phase: PHASE1
-
Safety of the Buprenorphine Transdermal Delivery System in Subjects With Mod-to-Sev Pain Following Orthopedic Surgery.
NCT00315835 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Treatment of Experimental Pain in Opioid Dependent Persons on Methadone or Buprenorphine Maintenance
NCT01642030 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Standard of Care Reduced Dose Versus Full Dose Buprenorphine/Naloxone in the Perioperative Period on Pain Control and Post-Operative Opioid Use Disorder Symptoms
NCT04091009 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Comparison of How Likely it is That Different Tablets of Oxycodone Will be Broken up and Snorted by Adults Who Sometimes Take Drugs for Pleasure
NCT03765346 ·Status: COMPLETED ·Phase: PHASE1
-
Blockade Efficacy of Buprenorphine/Naloxone For Opioid Dependence
NCT00134888 ·Status: COMPLETED ·Phase: NA
-
Medicinal Dependence and Chronic Pain: Addictive Evaluation in CETD
NCT03635346 ·Status: COMPLETED
-
Use of Transcranial Magnetic Stimulation to Reduce Craving for Individuals With Opioid Use Disorder Taking Buprenorphine
NCT03653169 ·Status: WITHDRAWN ·Phase: NA
-
Effects of Ketamine On Precipitated Opioid Withdrawal Under General Anaesthesia
NCT00300794 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Abuse Potential of Oxymorphone Compared to Other Mu Opioid Agonists.
NCT03389750 ·Status: COMPLETED ·Phase: PHASE2
-
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6
NCT00000331 ·Status: WITHDRAWN ·Phase: PHASE2
-
Open Label Placebo to Reduce Prescription Opioid Use
NCT05014230 ·Status: UNKNOWN ·Phase: NA